Compugen Ltd. (CGEN)
Nasdaq: CGEN · Biological Products, (No Diagnostic Substances) · Holon, IL · filing with the SEC since 2001
Who owns Compugen Ltd.
As filed with the SECHolders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
13
report now, of 13 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
Bristol-Myers Squibb Co.
SCHEDULE 13G/A · filed Feb 14, 2025 · Ordinary Shares, par value NIS 0.01 · reported falling below 5%
What CGEN reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 20-F filed Mar 2, 2026.
Insider tradesForm 4
12sales
0purchases
12sales on a scheduled plan
2people selling
$100,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Levine Zurit | SVP, Business Development | 9 | $100,000 | 9 | 0 | $0 |
| Ophir Eran | President and CEO | 3 | $0 | 3 | 0 | $0 |